HK Stock MarketDetailed Quotes

09939 KINTOR PHARMA-B

Watchlist
  • 1.260
  • +0.010+0.80%
Not Open May 9 16:08 CST
563.85MMarket Cap-3.36P/E (TTM)

KINTOR PHARMA-B Key Stats

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
(FY)Dec 31, 2020
(Q6)Jun 30, 2020
Turnover
--5M
----
----
----
----
----
--34.23M
----
----
----
Operating income
5M
34.23M
Cost of sales
76.96%-9.73M
--1.13M
---42.23M
----
----
----
----
----
----
----
Operating expenses
76.96%-9.73M
1.13M
-42.23M
Gross profit
88.80%-4.73M
1.13M
-42.23M
34.23M
Selling expenses
-280.27%-26.56M
79.58%-1.76M
65.64%-6.98M
18.80%-8.64M
-38.29%-20.33M
-72.88%-10.64M
-70.35%-14.7M
-71.21%-6.16M
-2,467.86%-8.63M
---3.6M
Administrative expenses
30.57%-61.83M
33.78%-33.91M
32.67%-89.05M
21.80%-51.2M
-28.08%-132.25M
-32.04%-65.48M
-33.99%-103.26M
-10.15%-49.59M
-135.21%-77.06M
-271.63%-45.02M
Research and development expenses
91.68%-78.14M
76.11%-39.33M
-13.40%-938.91M
64.30%-164.62M
-7.82%-827.97M
-63.40%-461.09M
-133.58%-767.94M
-90.18%-282.18M
-53.61%-328.76M
-65.92%-148.38M
Impairment and provision
---1.21M
----
----
----
----
----
----
----
----
----
-Other impairment is provision
---1.21M
----
----
----
----
----
----
----
----
----
Special items of operating profit
55.47%27.89M
-57.76%7.62M
-50.19%17.94M
-14.53%18.03M
198.75%36.02M
56.01%21.09M
113.34%12.06M
283.65%13.52M
-590.46%-90.4M
-15.71%3.52M
Operating profit
86.35%-144.57M
67.90%-66.26M
-12.14%-1.06B
60.00%-206.44M
-12.50%-944.53M
-59.10%-516.11M
-66.31%-839.6M
-67.68%-324.4M
-120.76%-504.85M
-98.71%-193.46M
Financing cost
4.26%-9.28M
13.80%-5.22M
-18.36%-9.69M
-162.59%-6.05M
-228.27%-8.19M
-62.25%-2.3M
26.15%-2.49M
28.46%-1.42M
13.19%-3.38M
-73.21%-1.99M
Share of profits of associates
-2,848.08%-1.43M
----
109.15%52K
---131K
---568K
----
----
----
----
----
Earning before tax
85.47%-155.27M
66.38%-71.48M
-12.12%-1.07B
58.99%-212.62M
-13.20%-953.28M
-59.11%-518.41M
-65.69%-842.1M
-66.71%-325.82M
-118.52%-508.23M
-98.41%-195.45M
Tax
-100.22%-18K
-103.55%-18K
841.11%8.04M
5,733.33%507K
---1.09M
---9K
----
----
---73K
----
After-tax profit from continuing operations
85.36%-155.29M
66.29%-71.49M
-11.15%-1.06B
59.09%-212.11M
-13.33%-954.37M
-59.11%-518.42M
-65.67%-842.1M
-66.71%-325.82M
-118.55%-508.3M
-98.41%-195.45M
Earning after tax
85.36%-155.29M
66.29%-71.49M
-11.15%-1.06B
59.09%-212.11M
-13.33%-954.37M
-59.11%-518.42M
-65.67%-842.1M
-66.71%-325.82M
-118.55%-508.3M
-98.41%-195.45M
Profit attributable to shareholders
85.36%-155.29M
66.29%-71.49M
-11.15%-1.06B
59.09%-212.11M
-13.33%-954.37M
-59.11%-518.42M
-65.67%-842.1M
-66.71%-325.82M
-118.55%-508.3M
-98.41%-195.45M
Basic earnings per share
85.43%-0.36
66.00%-0.17
2.37%-2.47
64.79%-0.5
-7.20%-2.53
-52.69%-1.42
-43.90%-2.36
-29.17%-0.93
-69.07%-1.64
-67.44%-0.72
Diluted earnings per share
85.43%-0.36
66.00%-0.17
2.37%-2.47
64.79%-0.5
-7.20%-2.53
-52.69%-1.42
-43.90%-2.36
-29.17%-0.93
-69.07%-1.64
-67.44%-0.72
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
--
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Auditor
--
--
PricewaterhouseCoopers
--
PricewaterhouseCoopers
--
PricewaterhouseCoopers
--
PricewaterhouseCoopers
--
(FY)Dec 31, 2024(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021(FY)Dec 31, 2020(Q6)Jun 30, 2020
Turnover --5M----------------------34.23M------------
Operating income 5M34.23M
Cost of sales 76.96%-9.73M--1.13M---42.23M----------------------------
Operating expenses 76.96%-9.73M1.13M-42.23M
Gross profit 88.80%-4.73M1.13M-42.23M34.23M
Selling expenses -280.27%-26.56M79.58%-1.76M65.64%-6.98M18.80%-8.64M-38.29%-20.33M-72.88%-10.64M-70.35%-14.7M-71.21%-6.16M-2,467.86%-8.63M---3.6M
Administrative expenses 30.57%-61.83M33.78%-33.91M32.67%-89.05M21.80%-51.2M-28.08%-132.25M-32.04%-65.48M-33.99%-103.26M-10.15%-49.59M-135.21%-77.06M-271.63%-45.02M
Research and development expenses 91.68%-78.14M76.11%-39.33M-13.40%-938.91M64.30%-164.62M-7.82%-827.97M-63.40%-461.09M-133.58%-767.94M-90.18%-282.18M-53.61%-328.76M-65.92%-148.38M
Impairment and provision ---1.21M------------------------------------
-Other impairment is provision ---1.21M------------------------------------
Special items of operating profit 55.47%27.89M-57.76%7.62M-50.19%17.94M-14.53%18.03M198.75%36.02M56.01%21.09M113.34%12.06M283.65%13.52M-590.46%-90.4M-15.71%3.52M
Operating profit 86.35%-144.57M67.90%-66.26M-12.14%-1.06B60.00%-206.44M-12.50%-944.53M-59.10%-516.11M-66.31%-839.6M-67.68%-324.4M-120.76%-504.85M-98.71%-193.46M
Financing cost 4.26%-9.28M13.80%-5.22M-18.36%-9.69M-162.59%-6.05M-228.27%-8.19M-62.25%-2.3M26.15%-2.49M28.46%-1.42M13.19%-3.38M-73.21%-1.99M
Share of profits of associates -2,848.08%-1.43M----109.15%52K---131K---568K--------------------
Earning before tax 85.47%-155.27M66.38%-71.48M-12.12%-1.07B58.99%-212.62M-13.20%-953.28M-59.11%-518.41M-65.69%-842.1M-66.71%-325.82M-118.52%-508.23M-98.41%-195.45M
Tax -100.22%-18K-103.55%-18K841.11%8.04M5,733.33%507K---1.09M---9K-----------73K----
After-tax profit from continuing operations 85.36%-155.29M66.29%-71.49M-11.15%-1.06B59.09%-212.11M-13.33%-954.37M-59.11%-518.42M-65.67%-842.1M-66.71%-325.82M-118.55%-508.3M-98.41%-195.45M
Earning after tax 85.36%-155.29M66.29%-71.49M-11.15%-1.06B59.09%-212.11M-13.33%-954.37M-59.11%-518.42M-65.67%-842.1M-66.71%-325.82M-118.55%-508.3M-98.41%-195.45M
Profit attributable to shareholders 85.36%-155.29M66.29%-71.49M-11.15%-1.06B59.09%-212.11M-13.33%-954.37M-59.11%-518.42M-65.67%-842.1M-66.71%-325.82M-118.55%-508.3M-98.41%-195.45M
Basic earnings per share 85.43%-0.3666.00%-0.172.37%-2.4764.79%-0.5-7.20%-2.53-52.69%-1.42-43.90%-2.36-29.17%-0.93-69.07%-1.64-67.44%-0.72
Diluted earnings per share 85.43%-0.3666.00%-0.172.37%-2.4764.79%-0.5-7.20%-2.53-52.69%-1.42-43.90%-2.36-29.17%-0.93-69.07%-1.64-67.44%-0.72
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards IASIASIASIASIASIASIASIASIASIAS
Audit Opinions ----Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--
Auditor ----PricewaterhouseCoopers--PricewaterhouseCoopers--PricewaterhouseCoopers--PricewaterhouseCoopers--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights

Warren Buffett Portfolio Warren Buffett Portfolio

Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.

Unlock Now

Discussing

Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve Show More